The biologics industry comprises
companies manufacturing biological products. Biological products include a wide
range of products such as vaccines, somatic cells, tissues, and recombinant
therapeutic proteins. Biologics can be composed of sugars, proteins, or
nucleic acids or complex combinations of these substances, or may be living
entities such as cells and tissues. These products are isolated from natural
sources such as human, animal, and microorganisms by biotechnological methods
and other cutting-edge technologies. Specifically, most biologic
medicines are developed using recombinant DNA (rDNA) technology.
Biologics Global Market Report 2019 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the global Biologics industry.
Order The Report At:
• The Biologics market size
characteristics section of the report defines and explains the market.
• The Vaccines market size
section gives the market size ($b) covering both the historic growth of the
market and forecasting the future. Drivers and restraints looks at the external
factors supporting and controlling the growth of the market.
• Vaccines market segmentations
break down the market into sub markets.
• The regional and country
breakdowns section gives an analysis of the Biologics industry in each
geography and the size of the market by geography and compares their historic
and forecast growth. It covers all the regions, key developed countries and
major emerging markets. It draws comparisons with country populations and economies
to understand the importance of the market by country and how this is changing.
• Competitive landscape gives a
description of the competitive nature of the Biologics market Industry, market
shares, and a description of the leading companies. Key financial deals which
have shaped the market in recent years are identified.
• The Biologics trends and
strategies section highlights likely future developments in the market and
suggests approaches companies can take to exploit this.
• The Biologics Industry section
of the report gives context. It compares the Biologics market with other
segments of the Global Pharmaceuticals market by size and growth, historic and
forecast. It analyses GDP proportion, expenditure per capita, Biologics
indicators comparison.
Scope
Markets Covered: Monoclonal Antibodies, Therapeutic Proteins,
Vaccines
Companies Mentioned: Amgen, AbbVie, Johnson & Johnson,
Bristol-Meyers Squibb, Pfizer Inc., Eli Lilly and Company, F. Hoffmann- La
Roche, Merck & Co., GlaxoSmithKline, Sanofi
Countries: USA, UK, Germany, France, Italy, Spain, Russia, Brazil,
Australia, China, India, Japan
Regions: Asia-Pacific, North America, South America, Western
Europe, Eastern Europe, Middle East, Africa.
Time Series: Five years historic and forecast.
Data: Ratios of market size and growth to related markets,
population, GDP
Data Segmentations: Country historic and forecast data, market
share of competitors, market segments.
Sourcing And Referencing: Data and analysis throughout the report
is sourced using end notes.
Download A Sample Of
The Report: https://www.thebusinessresearchcompany.com/sample.aspx?id=792&type=smp
About The Business Research Company:
The Business Research Company is
a Business Intelligence Company which excels in company, market and consumer
research. It has offices in the UK, the US and India and a network of trained
researchers in 15 countries globally.
Contact Information
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow us on LinkedIn: https://in.linkedin.com/company/the-business-research-company
No comments:
Post a Comment